Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

support including GMP supply of drug product for a first-in-human trial. Quell retains an option to co-develop the optioned T1D candidate in the United States in exchange for additional milestone ...

and controls support for the preclinical studies and supply the selected drug under good manufacturing practices protocols for a first-in-human trial. Under the terms of its deal with AstraZeneca, ...

Help a Diabetic Child is a Naples non-profit focused on helping families facing diabetes. Insulin pumps cost roughly $50 and ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Hims & Hers (NYSE:HIMS) has launched an online GLP-1 supply tracker where people can share information about where the ...

Court Square Capital Partners has agreed to sell Advanced Diabetes Supply Group, a Carlsbad, California-based distributor of durable medical equipment specializing in diabetes supplies, to Cardinal ...

Physicians and company management will own the remaining 29% after the Cardinal deal closes. The addition of Advanced ...